Sung-A Chang

Sung-A Chang

Auto-generated profile, based on publicly available information

Sung-A Chang

Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2008 in JACC
Verified
Journal Article
Closed access
ECEue-Keun Choi
Eue-Keun Choi
SCSang Il Choi
Sang Il Choi
JRJuan J. Rivera
Juan J. Rivera
KNKhurram Nasir
Khurram Nasir
SCSung-A. Chang
Sung-A. Chang
HCHyuk-Jae Chang
Hyuk-Jae Chang

1 February 2015 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
MJMi-Ae Jang
Mi-Ae Jang
EKEun Kyoung Kim
Eun Kyoung Kim
HNHesung Now
Hesung Now
NNNhung T.H. Nguyen
Nhung T.H. Nguyen
WKWoo-Jong Kim
Woo-Jong Kim
CKChang-Seok Ki
Chang-Seok Ki

4 July 2006 in Circulation
Verified
Journal Article
Closed access
PDF file
HKHyun-Jae Kang
Hyun-Jae Kang
HYHan Young Yu
Han Young Yu
SNSang-Hoon Na
Sang-Hoon Na
SCSung-A Chang
Sung-A Chang
KPKyung-Woo Park
Kyung-Woo Park
HKHyoSoo Kim
HyoSoo Kim
Background— The efficacy of intracoronary infusion of granulocyte colony-stimulating factor (G-CSF) mobilized peripheral blood stem cells (PBSCs) has not been compared between patients with acute (AMI) versus old myocardial infarction (OMI). In addition, the potential risk of restenosis associated with G-CSF–based stem cell therapy has not been evaluated in the setting of drug eluting stent (DES) implantation. Methods and Results— We randomly allocated 96 patients with myocardial infarction who underwent coronary revascularization with DES for the culprit lesion into 4 groups. Eighty-two patients completed 6-month follow-up; AMI cell infusion (n=25), AMI control (n=25), OMI cell infusion (n=16), and OMI control group (n=16). In cell infusion groups, PBSCs were mobilized by G-CSF for 3 days and delivered to infarcted myocardium via intracoronary infusion. The AMI cell infusion group showed a significant additive improvement in left ventricular ejection fraction (LVEF) and remodeling compared with controls (change of LVEF: +5.1±9.1% versus −0.2±8.6%, P <0.05; change of end-systolic volume: −5.4±17.0 mL versus 6.5±21.9 mL, P <0.05). In OMI patients, however, there was no significant change of LVEF and ventricular remodeling in spite of significant improvement of coronary flow reserve after cell infusion. G-CSF–based cell therapy did not aggravate neointimal growth with DES implantation. Conclusions— Intracoronary infusion of mobilized PBSCs with G-CSF improves LVEF and remodeling in patients with AMI but is less definite in patients with OMI. G-CSF–based stem cell therapy with DES implantation is both feasible and safe, eliminating any potential for restenosis.

12 February 2013 in Circulation
Verified
Journal Article
Closed access
JCJin-Ho Choi
Jin-Ho Choi
SCSung-A Chang
Sung-A Chang
JCJin-Oh Choi
Jin-Oh Choi
YSYoung Bin Song
Young Bin Song
JHJoo-Yong Hahn
Joo-Yong Hahn
HGHyeon-Cheol Gwon
Hyeon-Cheol Gwon
Background—: Despite complete interruption of antegrade coronary artery flow in the setting of a chronic total occlusion (CTO), clinical recognition of myocardial infarction is often challenging. Using cardiac MRI, we investigated the frequency and extent of myocardial infarction in patients with CTO, and assessed their relationship with regional systolic function and the extent of angiographic collateral flow. Methods and Results—: We included 170 consecutive patients (median age, 62 years) with angiographically documented CTO. Regional late gadolinium enhancement and wall motion score index were assessed by cardiac MRI with the use of a 17-segment model. Angiographic collateral flow was assessed by the collateral connection grade and the Rentrop score. Evidence of previous myocardial infarction was found in 25% of patients by ECG Q waves, in 69% by regional wall motion abnormality, and in 86% of patients by late gadolinium enhancement. Increased angiographic collateral flow was associated with a lower frequency of Q waves on ECG, and a lower regional wall motion score index, late gadolinium enhancement volume (%), and degree of late gadolinium enhancement transmurality (all P <0.001), as well. Conclusions—: The frequency of myocardial infarction in territories subtended by CTO is significantly higher than previously recognized. The degree of myocardial injury downstream epicardial CTO is inversely correlated with the degree of angiographic collaterals.

1 February 2013 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
SPSung-Ji Park
Sung-Ji Park
MEMaurice Enriquez-Sarano
Maurice Enriquez-Sarano
SCSung-A. Chang
Sung-A. Chang
JCJin-Oh Choi
Jin-Oh Choi
SLSang-Chol Lee
Sang-Chol Lee
JOJae K. Oh
Jae K. Oh

5 September 2017 in Health and Quality of Life Outcomes
Verified
Journal Article
Open access
PDF file
JMJu Ryoung Moon
Ju Ryoung Moon
JHJune Huh
June Huh
JSJinyoung Song
Jinyoung Song
IKI-Seok Kang
I-Seok Kang
SPSeung Woo Park
Seung Woo Park
TJTae-Gook Jun
Tae-Gook Jun
The Center for Epidemiological Studies Depression Scale (CES-D) is an instrument that is commonly used to screen for depression in patients with chronic disease, but the characteristics of the CES-D in adults with congenital heart disease (CHD) have not yet been studied. The aim of this study was to investigate the criterion validities and the predictive powers of the CES-D for depression and anxiety disorders in adults with CHD. Two hundred patients were screened with the CES-D and secondarily interviewed with a diagnostic instrument, i.e., the Mini International Neuropsychiatric Instrument. The sensitivity and specificity values of the CES-D were calculated by cross-tabulation at different cutoff scores. Receiver operating characteristic (ROC) curves were used to assess the optimal cutoff point for each disorder and to assess the predictive power of the instrument. The CES-D exhibited satisfactory criterion validities for depression and for all combinations of depression and/or anxiety. With a desired sensitivity of at least 80%, the optimal cutoff scores were 18. The predictive power of the CES-D in the patients was best for major depression and dysthymia (area under the ROC curve: 0.92) followed by the score for any combination of depression and/or anxiety (0.88). The use of CES-D to simultaneously screen for both depression and anxiety disorders may be useful in adults with CHD. Trial registration: CESDEP 212. Registered 2 March 2014 (retrospectively registered).